Argo Biopharma was founded in 2021 and develops siRNA therapies for cardiovascular, rare and metabolic diseases, as well as viral infections, among other conditions, its website shows. The company ...

The number of stages available to Milwaukee's music scene is growing, and that will include one more space as of this December. On Wednesday, The Argo, a new concert venue and event space, announced ...

Milwaukee’s newest live entertainment hub, The Argo, will officially open its doors next month inside the historic Fox Bay Theater in Whitefish Bay, anchoring a full-scale renovation of the 1949 Art ...

The Mighty Argo Cable Car gondola, just north of Clear Creek in Idaho Springs, is one step closer to completion with the lower terminal nearly fully built and visible from Interstate 70. At the top of ...

The transaction with siRNA specialist Argo includes $160m upfront, in addition to milestone and option payments that could reach $5.2bn. Credit: Melnikov Dmitriy via Shutterstock.com. Novartis has ...

Sept 3 (Reuters) - Swiss drugmaker Novartis (NOVN.S), opens new tab has signed an up to $5.2 billion licensing and options deal with Argo Biopharmaceutical for its experimental candidates that target ...

Novartis has returned to Argo Biopharmaceutical with $160 million in upfront cash to explore various cardiovascular meds in the Chinese biotech’s siRNA pipeline. The latest deal will allow Novartis to ...

Argo and Novartis expand collaboration, focusing on cardiovascular assets, including siRNA therapeutics for severe hypertriglyceridemia and mixed dyslipidemia. Novartis gains licensing rights and ...

Novartis is paying $160 million upfront to activate an R&D alliance with China's Argo Biopharma covering multiple cardiovascular disease drugs, including a lipid-lowering candidate in phase 2. Under ...

Novartis and Argo Biopharma go back to January 2024, when the pharma first bet up to $4.165 billion across two RNAi agreements targeting cardiovascular diseases. Novartis and Shanghai-based Argo ...